LYPLAL1 and metabolic dysfunction-associated steatotic liver disease: In a large-scale genome-wide association study (GWAS) conducted by The Genetics of Obesity-Related Liver Disease Consortium, LYPLAL1 rs12137855 was identified as being associated with NAFLD in a cohort of 7177 adults of European ancestry [43].